Use of the haemostatic agent TC-325 in the treatment of bleeding secondary to endoscopic retrograde cholangiopancreatography sphincterotomy

QJM. 2015 Jan;108(1):79-80. doi: 10.1093/qjmed/hcu135. Epub 2014 Jul 1.

Authors

V J Appleby¹, J M Hutchinson², C J Beckett², S Moreea²

Affiliations

¹ Department of Gastroenterology, Bradford Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, UK. victoria.appleby@bthft.nhs.uk.
² Department of Gastroenterology, Bradford Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, UK.

PMID: 24989779
DOI: 10.1093/qjmed/hcu135

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Cholangiopancreatography, Endoscopic Retrograde / adverse effects*
Common Bile Duct Diseases / drug therapy
Common Bile Duct Diseases / etiology
Gastrointestinal Hemorrhage / drug therapy
Gastrointestinal Hemorrhage / etiology
Hemostasis, Surgical / methods
Hemostatics / therapeutic use*
Humans
Male
Minerals / therapeutic use*
Postoperative Hemorrhage / drug therapy*
Postoperative Hemorrhage / etiology
Sphincter of Oddi / surgery
Sphincterotomy, Endoscopic / adverse effects*

Substances

Hemostatics
Minerals
hemospray